HCC827 GR5 and Calu-3 cells (a NSCLC cell line with epithelial features as previously reported [37]) were treated with 2 ng/ml TGF-β1 for 72 hours with or without 1μM gefitinib. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.